Anticancer effects of ikarugamycin and astemizole identified in a screen for stimulators of cellular immune responses
Shuai Zhang(Union Hospital), Guido Kroemer(Inserm)
Cited by 17
Related Papers
Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors
|Science|2017|5.4k
Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009
|Cell Death and Differentiation|2008|3.3k
The molecular machinery of regulated cell death
|Cell Research|2019|2.5k
Molecular definitions of cell death subroutines: recommendations of the Nomenclature Committee on Cell Death 2012
|Cell Death and Differentiation|2011|2.4k
Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death
|The Journal of Experimental Medicine|2005|1.5k